• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向人乳头瘤病毒 16 型 E7 癌基因的短干扰 RNA 的预测与实际脱靶效应之间缺乏相关性。

Lack of correlation between predicted and actual off-target effects of short-interfering RNAs targeting the human papillomavirus type 16 E7 oncogene.

机构信息

Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge CB2 1QP, UK.

出版信息

Br J Cancer. 2013 Feb 5;108(2):450-60. doi: 10.1038/bjc.2012.564. Epub 2013 Jan 8.

DOI:10.1038/bjc.2012.564
PMID:23299538
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3566827/
Abstract

BACKGROUND

When designing therapeutic short-interfering RNAs (siRNAs), off-target effects (OTEs) are usually predicted by computational quantification of messenger RNAs (mRNAs) that contain matches to the siRNA seed sequence in their 3' UTRs. It is assumed that the higher the number of predicted transcriptional OTEs, the greater the size of the actual OTE signature and the more detrimental the phenotypic consequences in target-negative cells.

METHODS

We tested this general assumption by investigating the OTEs of potential therapeutic siRNAs targeting the human papillomavirus (HPV) type-16 E7 oncogene. We studied HPV-negative squamous epithelial cells, from normal cervix (NCx) and skin (HaCaT), which would be vulnerable to 'bystander' OTEs following transfection in vivo.

RESULTS

We observed no correlation between the number of computationally predicted OTEs and the actual number of seed-dependent OTEs (P=0.76). On average only 20.5% of actual transcriptional OTEs were seed-dependent (i.e., predicted). The unpredicted OTEs included stimulation of innate immune pathways, as well as indirect (downstream) effects of other OTEs, which affected important cancer-associated pathways. Although most significant OTEs observed were seen in both NCx and HaCaT cells, only 0-5.9% of differentially expressed genes overlapped between the two cell types.

CONCLUSION

These data do not support the assumption that actual OTEs correlate well with predicted OTEs.

摘要

背景

在设计治疗性短干扰 RNA(siRNA)时,通常通过计算 3'UTR 中与 siRNA 种子序列匹配的信使 RNA(mRNA)的数量来预测脱靶效应(OTE)。人们认为,预测转录 OTE 的数量越多,实际 OTE 特征的大小就越大,对非靶细胞的表型后果就越不利。

方法

我们通过研究针对人乳头瘤病毒(HPV)16 型 E7 癌基因的潜在治疗性 siRNA 的 OTE 来检验这一普遍假设。我们研究了 HPV 阴性的鳞状上皮细胞,来自正常宫颈(NCx)和皮肤(HaCaT),这些细胞在体内转染后容易受到“旁观者”OTE 的影响。

结果

我们没有观察到计算预测的 OTE 数量与实际种子依赖性 OTE 数量之间存在相关性(P=0.76)。平均而言,只有 20.5%的实际转录 OTE 是种子依赖性的(即预测的)。未预测的 OTE 包括先天免疫途径的刺激,以及其他 OTE 的间接(下游)效应,这些效应影响了重要的癌症相关途径。尽管观察到的大多数显著 OTE 都出现在 NCx 和 HaCaT 细胞中,但两种细胞类型之间只有 0-5.9%的差异表达基因重叠。

结论

这些数据不支持实际 OTE 与预测 OTE 相关性良好的假设。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42fc/3566827/6533dba26c6f/bjc2012564f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42fc/3566827/d374f3349cbe/bjc2012564f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42fc/3566827/b52289f2fa21/bjc2012564f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42fc/3566827/ffa1af9a367b/bjc2012564f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42fc/3566827/a659b19bf806/bjc2012564f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42fc/3566827/d12d6ef3ceed/bjc2012564f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42fc/3566827/6533dba26c6f/bjc2012564f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42fc/3566827/d374f3349cbe/bjc2012564f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42fc/3566827/b52289f2fa21/bjc2012564f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42fc/3566827/ffa1af9a367b/bjc2012564f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42fc/3566827/a659b19bf806/bjc2012564f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42fc/3566827/d12d6ef3ceed/bjc2012564f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42fc/3566827/6533dba26c6f/bjc2012564f6.jpg

相似文献

1
Lack of correlation between predicted and actual off-target effects of short-interfering RNAs targeting the human papillomavirus type 16 E7 oncogene.靶向人乳头瘤病毒 16 型 E7 癌基因的短干扰 RNA 的预测与实际脱靶效应之间缺乏相关性。
Br J Cancer. 2013 Feb 5;108(2):450-60. doi: 10.1038/bjc.2012.564. Epub 2013 Jan 8.
2
Transcriptional gene silencing of HPV16 E6/E7 induces growth inhibition via apoptosis in vitro and in vivo.HPV16E6/E7 的转录基因沉默通过体外和体内的细胞凋亡诱导生长抑制。
Gynecol Oncol. 2012 Feb;124(2):296-302. doi: 10.1016/j.ygyno.2011.10.028. Epub 2011 Nov 3.
3
siRNA-induced immunostimulation through TLR7 promotes antitumoral activity against HPV-driven tumors in vivo.TLR7 介导的 siRNA 诱导免疫刺激促进 HPV 驱动肿瘤的抗肿瘤活性体内。
Immunol Cell Biol. 2012 Feb;90(2):187-96. doi: 10.1038/icb.2011.19. Epub 2011 Mar 22.
4
Loss of Dependence on Continued Expression of the Human Papillomavirus 16 E7 Oncogene in Cervical Cancers and Precancerous Lesions Arising in Fanconi Anemia Pathway-Deficient Mice.范可尼贫血通路缺陷小鼠发生的宫颈癌及癌前病变中对人乳头瘤病毒16 E7癌基因持续表达的依赖性丧失
mBio. 2016 May 17;7(3):e00628-16. doi: 10.1128/mBio.00628-16.
5
Depletion of HPV16 early genes induces autophagy and senescence in a cervical carcinogenesis model, regardless of viral physical state.HPV16 早期基因缺失可诱导宫颈癌发生模型中发生自噬和衰老,而与病毒的物理状态无关。
J Pathol. 2013 Nov;231(3):354-66. doi: 10.1002/path.4244.
6
Correlation of E6 and E7 levels in high-risk HPV16 type cervical lesions with CCL20 and Langerhans cells.高危型人乳头瘤病毒16型宫颈病变中E6和E7水平与CCL20及朗格汉斯细胞的相关性
Genet Mol Res. 2015 Sep 8;14(3):10473-81. doi: 10.4238/2015.September.8.8.
7
Silencing of E7 oncogene restores functional E-cadherin expression in human papillomavirus 16-transformed keratinocytes.E7癌基因沉默可恢复人乳头瘤病毒16型转化的角质形成细胞中功能性E-钙黏蛋白的表达。
Carcinogenesis. 2008 Jul;29(7):1441-7. doi: 10.1093/carcin/bgn145. Epub 2008 Jun 19.
8
Highly potent and specific siRNAs against E6 or E7 genes of HPV16- or HPV18-infected cervical cancers.针对 HPV16 或 HPV18 感染的宫颈癌的 E6 或 E7 基因的高效特异的 siRNA。
Cancer Gene Ther. 2010 Dec;17(12):827-36. doi: 10.1038/cgt.2010.38. Epub 2010 Oct 1.
9
HPV-16 E6/E7 promotes cell migration and invasion in cervical cancer via regulating cadherin switch in vitro and in vivo.人乳头瘤病毒16型E6/E7蛋白通过在体内外调节钙黏蛋白转换促进宫颈癌细胞的迁移和侵袭。
Arch Gynecol Obstet. 2015 Dec;292(6):1345-54. doi: 10.1007/s00404-015-3787-x. Epub 2015 Jun 21.
10
Persistence of high-grade cervical dysplasia and cervical cancer requires the continuous expression of the human papillomavirus type 16 E7 oncogene.高级别宫颈发育异常和宫颈癌的持续存在需要人乳头瘤病毒16型E7癌基因的持续表达。
Cancer Res. 2009 May 15;69(10):4407-14. doi: 10.1158/0008-5472.CAN-09-0023. Epub 2009 May 12.

引用本文的文献

1
RNAi in Pest Control: Critical Factors Affecting dsRNA Efficacy.害虫防治中的RNA干扰:影响双链RNA功效的关键因素
Insects. 2025 Jul 18;16(7):737. doi: 10.3390/insects16070737.
2
identification of off-target pesticidal dsRNA binding in honey bees ().蜜蜂中脱靶杀虫双链RNA结合的鉴定()
PeerJ. 2017 Dec 13;5:e4131. doi: 10.7717/peerj.4131. eCollection 2017.
3
Identification of host transcriptional networks showing concentration-dependent regulation by HPV16 E6 and E7 proteins in basal cervical squamous epithelial cells.

本文引用的文献

1
Primary human cervical carcinoma cells require human papillomavirus E6 and E7 expression for ongoing proliferation.原发性人宫颈癌细胞需要人乳头瘤病毒 E6 和 E7 的表达才能持续增殖。
Virology. 2012 Jan 5;422(1):114-24. doi: 10.1016/j.virol.2011.10.012. Epub 2011 Nov 5.
2
Recent advances in understanding of the immunological off-target effects of siRNA.理解 siRNA 的免疫脱靶效应的最新进展。
Curr Gene Ther. 2011 Dec;11(6):532-43. doi: 10.2174/156652311798192770.
3
Networks controlling mRNA decay in the immune system.免疫系统中控制 mRNA 降解的网络。
鉴定 HPV16 E6 和 E7 蛋白在基底宫颈鳞状上皮细胞中表现出浓度依赖性调节的宿主转录网络。
Sci Rep. 2016 Jul 26;6:29832. doi: 10.1038/srep29832.
4
Overexpression of the oncostatin-M receptor in cervical squamous cell carcinoma is associated with epithelial-mesenchymal transition and poor overall survival.抑瘤素-M受体在宫颈鳞状细胞癌中的过表达与上皮-间质转化及总体生存率低相关。
Br J Cancer. 2016 Jul 12;115(2):212-22. doi: 10.1038/bjc.2016.199. Epub 2016 Jun 28.
5
HPV16 oncogene expression levels during early cervical carcinogenesis are determined by the balance of epigenetic chromatin modifications at the integrated virus genome.早期宫颈癌发生过程中HPV16癌基因的表达水平由整合病毒基因组上的表观遗传染色质修饰平衡所决定。
Oncogene. 2016 Sep 8;35(36):4773-86. doi: 10.1038/onc.2016.8. Epub 2016 Feb 15.
6
MicroRNA-7 as a tumor suppressor and novel therapeutic for adrenocortical carcinoma.微小RNA-7作为肾上腺皮质癌的肿瘤抑制因子及新型治疗手段
Oncotarget. 2015 Nov 3;6(34):36675-88. doi: 10.18632/oncotarget.5383.
7
Depletion of polycistronic transcripts using short interfering RNAs: cDNA synthesis method affects levels of non-targeted genes determined by quantitative PCR.使用短发夹 RNA 耗尽多顺反子转录本:cDNA 合成方法会影响定量 PCR 测定的非靶向基因的水平。
Virol J. 2013 May 21;10:159. doi: 10.1186/1743-422X-10-159.
Wiley Interdiscip Rev RNA. 2010 Nov-Dec;1(3):432-56. doi: 10.1002/wrna.13.
4
Overexpression of the oncostatin M receptor in cervical squamous cell carcinoma cells is associated with a pro-angiogenic phenotype and increased cell motility and invasiveness.在宫颈鳞状细胞癌细胞中过表达的骨桥蛋白受体与促血管生成表型以及增加的细胞迁移和侵袭性相关。
J Pathol. 2011 Nov;225(3):448-62. doi: 10.1002/path.2968. Epub 2011 Sep 26.
5
Enhanced specificity of HPV16 E6E7 siRNA by RNA-DNA chimera modification.通过 RNA-DNA 嵌合体修饰提高 HPV16 E6E7 siRNA 的特异性。
Cancer Gene Ther. 2011 Aug;18(8):587-97. doi: 10.1038/cgt.2011.28. Epub 2011 Jun 10.
6
Enrichment map: a network-based method for gene-set enrichment visualization and interpretation.富集图谱:一种基于网络的基因集富集可视化和解释方法。
PLoS One. 2010 Nov 15;5(11):e13984. doi: 10.1371/journal.pone.0013984.
7
SylArray: a web server for automated detection of miRNA effects from expression data.SylArray:一个从表达数据中自动检测 miRNA 效应的网络服务器。
Bioinformatics. 2010 Nov 15;26(22):2900-1. doi: 10.1093/bioinformatics/btq545. Epub 2010 Sep 24.
8
Potential use of RNA interference in cancer therapy.RNA 干扰在癌症治疗中的潜在应用。
Expert Rev Mol Med. 2010 Aug 18;12:e26. doi: 10.1017/S1462399410001584.
9
A status report on RNAi therapeutics.RNA干扰疗法的现状报告。
Silence. 2010 Jul 8;1(1):14. doi: 10.1186/1758-907X-1-14.
10
MicroRNA-1 inhibits myocardin-induced contractility of human vascular smooth muscle cells.MicroRNA-1 抑制心肌营养素诱导的人血管平滑肌细胞收缩性。
J Cell Physiol. 2010 Nov;225(2):506-11. doi: 10.1002/jcp.22230.